Pharma Firms Swap Assets
Novartis is exiting vaccines, GlaxoSmithKline is shedding oncology drugs, and Eli Lilly & Co.
Read moreFood and Drug Dept. aims to regularise pharmaceutical industry
The possibility exists that close to 50 per cent of malaria drugs on the local market do not...
Read morePfizer eyes AstraZeneca for $100 billion acquisition
After making a failed bid for AstraZeneca in January, pharmaceutical heavyweight Pfizer is again...
Read moreShould drug firms make payments to doctors?
Gifts and payments to US doctors from drug firms are seen by some as encouraging unnecessary...
Read moreCabinet Secretary Ajit Seth calls meet of top officials on India-US pharmaceuticals issue
NEW DELHI: Cabinet Secretary Ajit Seth has called a meeting of top bureaucrats on Monday to chalk...
Read morePharmaceutical market of KSA estimated at SR13.5 billion
The volume of pharmaceutical market in the Kingdom is estimated at nearly SR13.5 billion, including...
Read more'Don't Miss Early Symptoms of Ebola'
The Pharmaceutical Society of Ghana (PSGH) is appealing to pharmacists especially those in...
Read moreAbbVie announces availability of new advanced Parkinson's treatment in Canada
AbbVie has announced that a new treatment called Duodopa (levodopa/carbidopa intestinal gel) is now...
Read morePharmaceutical multinationals rethink rebate marketing in China
NANNING, April 11 (Xinhua) -- Pharmaceutical multinationals operating in China are rethinking...
Read moreIdea of New Attention Disorder Spurs Research, and Debate
With more than six million American children having received a diagnosis of attention deficit...
Read more



